Profile
Karen B. Chapman is the founder of Origen Therapeutics, Inc. Dr. Chapman was Vice President-Research at Insight Molecular Diagnostics, Inc. from 2011 to 2017.
Dr. Chapman completed graduate studies at Cornell University and earned a doctorate from The Johns Hopkins University School of Medicine in 1991.
Former positions of Karen Chapman
| Companies | Position | End |
|---|---|---|
| INSIGHT MOLECULAR DIAGNOSTICS INC. | Chief Tech/Sci/R&D Officer | 22/03/2017 |
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Founder | - |
Training of Karen Chapman
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Cornell University
Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Origen Therapeutics, Inc.
Origen Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company, develops products from avian transgenic animal technology | Health Technology |
OncoCyte Corp.
OncoCyte Corp. BiotechnologyHealth Technology Focuses on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer | Health Technology |
The Johns Hopkins University School of Medicine
The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Karen Chapman
















